Back to top

Image: Bigstock

HealthEquity (HQY) Reports Q1 Earnings: What Key Metrics Have to Say

Read MoreHide Full Article

For the quarter ended April 2026, HealthEquity (HQY - Free Report) reported revenue of $354.64 million, up 7.2% over the same period last year. EPS came in at $1.24, compared to $0.97 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $354.43 million, representing a surprise of +0.06%. The company delivered an EPS surprise of +11.57%, with the consensus EPS estimate being $1.11.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how HealthEquity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Revenue- Service: $122.93 million versus the three-analyst average estimate of $121.69 million. The reported number represents a year-over-year change of +2.6%.
  • Revenue- Custodial: $174.33 million compared to the $175.56 million average estimate based on three analysts. The reported number represents a change of +11.4% year over year.
  • Revenue- Interchange: $57.38 million versus $58.34 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +5.1% change.

View all Key Company Metrics for HealthEquity here>>>

Shares of HealthEquity have returned +6.2% over the past month versus the Zacks S&P 500 composite's +5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in